JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)

SHA:603235 Revenue

JiangXi Tianxin Pharmaceutical had revenue of 555.73M CNY in the quarter ending September 30, 2026, with 9.27% growth. This brings the company's total for the last twelve months to 2.58B, up 15.87% year-over-year. In the year 2025, JiangXi Tianxin Pharmaceutical had annual revenue of 2.35B with 6.18% growth. That makes JiangXi Tianxin Pharmaceutical the 12,794th largest company in the world by revenue and 2,221st in China.

• Revenue (ttm): 2.58B
• Revenue Growth: +15.87%
• P/S Ratio: 4.30
• Revenue / Employee: 891.54K
• Employees: 2,893
• Market Cap: 11.10B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• B Vitamins 1.83B 78.0%
• Other Vitamins 288.06M 12.3%
• Fine Chemicals 205.07M 8.7%
• Unallocated Others 22.74M 1.0%

By Geography

Chart

• Overseas 1.26B 54.3%
• China 1.06B 45.7%

Fiscal year ended Dec 31, 2025 See the full SHA:603235 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.35B	136.47M	6.18%
Dec 31, 2024	2.21B	326.58M	17.35%
Dec 31, 2023	1.88B	-422.80M	-18.34%
Dec 31, 2022	2.30B	-217.64M	-8.63%
Dec 31, 2021	2.52B	218.84M	9.50%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error